SCHEMBL2967310

SCHEMBL2967310

CCCC1=C(c2ccco2)[CH]c2ccccc21

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTAFR P25105 1/20 0.32
ALDH1A1 P00352 6/20 0.32
KDM4E B2RXH2 5/20 0.32
HPGD P15428 5/20 0.32
HSD17B10 Q99714 4/20 0.32
TP53 P04637 2/20 0.32
MEN1 O00255 4/20 0.32
KMT2A Q03164 4/20 0.32
SMN1; SMN2 Q16637 3/20 0.32
TSHR P16473 2/20 0.32
NPC1 O15118 2/20 0.31
RAB9A P51151 2/20 0.31
POLB P06746 3/20 0.31
MAPT P10636 3/20 0.31
BLM P54132 3/20 0.31
L3MBTL1 Q9Y468 3/20 0.31
PKM P14618 2/20 0.31
ALOX15 P16050 2/20 0.31
CASP1 P29466 2/20 0.31
PTPN7 P35236 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2958864 0.78 PTPRC (0.30)
SCHEMBL2971548 0.77 PTPRC (0.33)
SCHEMBL2970242 0.77 ADRA1D (0.33)
SCHEMBL218029 0.76 ALDH1A1 (0.32) ALDH1A1KDM4EHPGDHSD17B10SMN1; SMN2
SCHEMBL2966757 0.76 ALDH1A1 (0.35) PTAFRALDH1A1KDM4EHPGDHSD17B10
SCHEMBL2972447 0.74 NR1H2 (0.33)
SCHEMBL2962857 0.74 MAOB (0.43) ALDH1A1KDM4ESMN1; SMN2NPC1RAB9A
SCHEMBL2970390 0.74 NR1H2 (0.33)
SCHEMBL2965681 0.73 SMN1; SMN2 (0.33) PTAFRALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL2971073 0.73 KDM4E (0.32) ALDH1A1KDM4EMAPTADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7276567-B2 Heterocyclic substituted metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-10-02 US claimed
US-7763562-B2 Heteroatom bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2010-07-27 US disclosed
US-7276567-B2 Heterocyclic substituted metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-10-02 US disclosed
US-20070135597-A1 Heteroatom bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. 2007-06-14 US disclosed
US-7214747-B2 Phosphorus substituted metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-05-08 US disclosed
US-7214746-B2 Phosphorus bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-05-08 US disclosed
US-20050261449-A1 Heterocyclic substituted metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENT INC. 2005-11-24 US disclosed
US-20050239981-A1 Phosphorus bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. 2005-10-27 US disclosed
US-20050239980-A1 Phosphorus substituted metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. 2005-10-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050239981-A1 Phosphorus bridged metallocene compounds for olefin polymerization PYM1, ZNF207, POLL PTAFR 1378/4885ALDH1A1 4206/4885KDM4E 1418/4885
US-20070135597-A1 Heteroatom bridged metallocene compounds for olefin polymerization AP2M1, AP1M1, PYM1 PTAFR 2379/4885ALDH1A1 4332/4885KDM4E 2177/4885
US-20050239980-A1 Phosphorus substituted metallocene compounds for olefin polymerization CCRL2, ARL1, OSBP2 PTAFR 1758/4885ALDH1A1 4248/4885KDM4E 3216/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.